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90 CONSEQUENCES OF EXCITOTOXICITY ON IN
VIVO-LABELED CHOLINERGIC NEURONS IN RAT
NUCLEUS BASALIS: TEMPORAL CHANGES IN
AMYLOID PRECURSOR PROTEIN EXPRESSION
Wolfgang Haertig∗, Department of Neurochemistry, Paul Flechsig Institute
for Brain Research, University of Leipzig, Leipzig, Germany; Paul G.M.
Luiten, Department of Molecular Neurobiology, University of Groningen,
Haren, The Netherlands; Tibor Harkany, Unit of Molecular Neurobiology,
Department of Medical Biochemistry and Biophysics, Karolinska Institute,
Stockholm, Sweden. Contact e-mail: tibor@cajal.mbb.ki.se
Background: Cholinergic neurons of the nucleus basalis (MBN) are dam-
aged in Alzheimer’s disease; and are vulnerable to N-methyl-d-aspartate
(NMDA) excitotoxicity. Objective: As the temporal profile of early patho-
logical changes in the MBN is sparsely known, we investigated several pa-
rameters of in vivo-labeled cholinergic neurons 4, 24, and 48 h after NMDA
infusion. Methods: Cholinergic cells were pre-labeled with carbocyanine
3 (Cy3)-192IgG. Twenty-four hour later 60 mM NMDA was infused in the
right MBN, while the contralateral nucleus was sham-lesioned. Results: Neu-
ronal damage, as indicated by decreased immunoreactivity for NMDA re-
ceptors, choline-acetyltransferase (ChAT) and p75 low-affinity neurotrophin
receptor (p75NTR), was detected as early as 4 h post-lesion. Fluoro-Jade, an
indicator of cellular damage, only labeled the lesion core at 4 h post-lesion.
Longer survival led to enhanced Fluoro-Jade labeling concomitant with loss
of ChAT immunoreactivity reaching a maximum at 24 h post-lesion. Signifi-
cant loss of p75NTR immunoreactivity was only detected 48 h after NMDA
infusion. In vivo labeling of cholinergic neurons exhibited a similar temporal
profile as ChAT immunoreactivity in the damaged MBN. Analysis of amy-
loid precursor protein (APP) expression in cholinergic and non-cholinergic
neurons revealed that almost all cholinergic cells were immunoreactive for
APP, whereas, only a fraction of non-cholinergic neurons expressed APP
under control conditions. ChAT-immunopositive cells withstanding NMDA
excitotoxicity maintained their APP immunoreactivity throughout the sur-
vival period investigated, whereas a decline of APP labeling was found in
non-cholinergic neurons. Conclusions: Our data demonstrate that excito-
toxicity leads to rapid dysfunction of cholinergic MBN neurons. Moreover,
cholinergic cells retain their APP expression under excitotoxic conditions
that might contribute to increased cortical APP concentrations after MBN
lesion. Finally, in vivo labeling with Cy3-192IgG is a sensitive tool to label
live cholinergic neurons under experimental circumstances.
91 REDUCED INSULIN DEGRADING ENZYME LEVELS
WITH CHRONIC GLUCOCORTICOID
ADMINISTRATION IN THE AGED MACAQUE
J.J. Kulstad∗, J. Leverenz, E.R. Peskind, D.G. Cook, P. McMillan, S. Craft,
University of Washington, Seattle, WA, USA.
Contact e-mail: jkulstad@u.washington.edu
Background: Cortisol levels have been shown to be elevated in AD, and
also increased with the presence of the APOE-4 allele for both control and
demented subjects (Peskind et al., 2001). Although hypercortisolemia may
contribute to the pathology of AD by lowering the threshold for neurodegen-
eration, it may also inhibit the function of Insulin Degrading Enzyme (IDE)
in vitro (Kupfer et al., 1994). IDE has been identified as a major protease
involved in Ab degradation in human brain (Qui et al., 1998). Objective:
The present study investigated the long term effects of glucocorticoid (GC)
administration on IDE levels in the primate brain. Methods: Sixteen retired
breeder Macaques (Macaca nemestrina) in middle to late life (mean age,
23.1 ± 1.0 years at death) were divided into eight pairs matched for age,
gender, and weight. Each pair was randomized to receive either high-dose hy-
drocortisone (cortisol) acetate or placebo for 12 months. Tissue samples from
the inferior frontal cortex were dissected from frozen slides, homogenized
and IDE was visualized by Western blot with a rabbit polyclonal antibody
IDE-3 (a gift of Dr. D. Selkoe). Samples were run in duplicate, IDE bands
were quantified using Kodak 1D software, and comparisons were made by
repeated measures ANCOVA normalized to a linear series of IDE samples
from human brain. Results: IDE protein levels were more than 22% lower in
macaques who received GC treatment compared with placebo treated con-
trols (P < 0.001). Conclusions: These preliminary findings indicate that
chronically elevated cortisol levels such as have been reported in AD may
contribute to a reduction in IDE protein levels in the brain.
92 COMPARATION OF THREE NEURODEGENERATIVE
ANIMAL MODELS INDUCED BY MITOCHONDRIAL
DEFICIT
Lan Zhang∗, Lin Li, Ru-yi Zhang, Cui-fei Ye, Li Zhang, Department of
Pharmacology, Xuan-wu Hospital of Capital University of Medical
Sciences, Beijing, China. Contact e-mail: lanizhg@hotmail.com
Background: Mitochondrial deficiency occurs in Pakinson’s disease (PD),
Huntington’s disease (HD) and Alzheimer’s disease (AD). Objective: We
compared the difference of behavior, pathology and neuro-transmitters among
these three neurodegenerative animal models to study the mechanisms of the
diseases. Methods: C57BL mice were treated with MPTP (mitochondrial
complex I inhibitor, ip) to mimic PD; SD rats treated with 3-NPA (complex
II inhibitor, ip) to mimic HD; SD rats administrated with NaN3 (complex
IV inhibitor) subcutaneously via a Alzet minipump to mimic AD. Learning
memory ability was determined by water maze and passive avoidance tests.
Rolling hole test, spontaneous motor activity and climing test were inves-
tigated to show the movement ability. HE staining to detect the neurons in
cortex and hippocampus, and immuno-histochemistry for tyrosine hydroxy-
lase (TH) to detect the dopaminergic neurons in striatum. The content of NE,
dopamine, 5-HT and their metabolic products in striatum were measured by
HPLC. Results: (1) MPTP mice showed damage of neurons in striatum and
the content of dopamine and its metabolic product DOPAC also decrease.
Model mice indicated movement disorder without learning-memory deficit.
(2) NaN3 rats showed damage of neurons in cortex and hippocampus, both
neurons and neuro-transmitters in striatum did not show any abnormality. So
model rats indicated learning-memory deficit without any movement disor-
der. (3) 3-NPA rats showed damage of neurons in striatum, cortex and hip-
pocampus, and the content of neuro-transmitters decreased in striatum too.
Model rats indicated both movement disorder and learning-memory deficit.
Conclusions: Different inhibition of mitochondrial complex induces the ab-
normality of neurons, neuro-transmitters and behaviors in disease-special
area of brain and results the disease-like disorders. These three animal mod-
